|
1.
|
その他
|
Response to the Letter by Kumaran and Sharma Regarding "Spatial Transcriptome Analysis of B7-H4 in Head and Neck Squamous Cell Carcinoma: A Novel Therapeutic Target for Anti-immune Checkpoint Inhibitors". 2025/10
|
|
2.
|
原著(症例報告除く)
|
Hepatic Sarcoidosis Mimicking a Metastatic Tumor: A Case Report 2025/08
|
|
3.
|
原著(症例報告除く)
|
Hepatocyte nuclear factor 4 alpha immunocytochemistry: A useful marker for detecting endocervical glandular lesions in alcohol-fixed smears. 2025/08
|
|
4.
|
原著(症例報告除く)
|
Spatial Transcriptome Analysis of B7-H4 in Head and Neck Squamous Cell Carcinoma: A Novel Therapeutic Target for Anti-Immune Checkpoint Inhibitors. 2025/06
|
|
5.
|
原著(症例報告除く)
|
Circadian clock-gated cell renewal controls time-dependent changes in taste sensitivity. 2025/05
|
|
6.
|
原著(症例報告除く)
|
High-Sensitivity PD-L1 Staining Using Clone 73-10 Antibody and Spatial Transcriptomics for Precise Expression Analysis in Non-Tumorous, Intraepithelial Neoplasia, and Squamous Cell Carcinoma of Head and Neck. 2025/05
|
|
7.
|
症例報告
|
Adenoid glioblastoma: Stromal hypovascularity and secretion of chondromodulin-I by tumor cells 2025/04
|
|
8.
|
症例報告
|
Diagnostic Dilemma of Rounded Atelectasis in the Left Lower Lobe Showing High Uptake of 18F-Fluorodeoxyglucose: A Surgical Conundrum. 2025/04
|
|
9.
|
症例報告
|
Primary Eosinophilic Panniculitis of the Greater Omentum in a Young Girl: A Case Report 2025/04
|
|
10.
|
原著(症例報告除く)
|
MRI navigation surgery for T4b rectal cancer using multiple minimally invasive surgical approaches 2025/03
|
|
11.
|
症例報告
|
Salvage Lung Resection of Aspergilloma Mimicking Tumor Regrowth after Immune Checkpoint Inhibitor Therapy for Stage IV Squamous Cell Lung Cancer: A Case Report 2025/03
|
|
12.
|
原著(症例報告除く)
|
Effectiveness and outcomes of endoscopic resection for superficial pharyngeal squamous cell carcinomas 2025/02
|
|
13.
|
原著(症例報告除く)
|
Hepatocyte Nuclear Factor 4α as a Sensitive Marker for Uterine Endocervical Adenocarcinomas and their Precursors 2025/01
|
|
14.
|
症例報告
|
A Case of Pulmonary Metastasis from Adenoid Cystic Carcinoma of the Hard Palate Exhibiting Ground Glass Nodules. 2025
|
|
15.
|
原著(症例報告除く)
|
Prognostic impact of lymph node invasion levels in patients with bladder cancer undergoing radical cystectomy and pelvic lymphadenectomy 2024/11
|
|
16.
|
原著(症例報告除く)
|
A case of gastritis caused by immune checkpoint inhibitor treated with infliximab 2024/09
|
|
17.
|
原著(症例報告除く)
|
Efficacy of Minor Salivary Glands as Indicators of Depth of Resection for Superficial Hypopharyngeal Carcinoma 2024/08
|
|
18.
|
症例報告
|
Giant cell glioblastoma with lipogenic differentiation in a patient with neurofibromatosis type 1: A case report 2024/08
|
|
19.
|
症例報告
|
H3 K27-altered diffuse midline glioma of the thalamus with formation of glio-fibrillary globular structures 2024/07
|
|
20.
|
原著(症例報告除く)
|
Impact of LAG-3/FGL1 pathway on immune evasive contexture and clinical outcomes in advanced urothelial carcinoma 2024/07
|
|
21.
|
症例報告
|
Emergency right lower lobectomy for severe pulmonary abscess in a pregnant woman at the 25th week of gestation: a case report 2024/05
|
|
22.
|
原著(症例報告除く)
|
Evaluating Cellularity Estimation Methods: Comparing AI Counting with Pathologists' Visual Estimates 2024/05
|
|
23.
|
原著(症例報告除く)
|
Morphological basis of the lung adenocarcinoma subtypes 2024/04
|
|
24.
|
症例報告
|
Alveolar adenoma with a single cyst: A case report 2024/02
|
|
25.
|
症例報告
|
Successful endoscopic resection for well-differentiated neuroendocrine tumor, Grade 1, in the hypopharynx 2024/02
|
|
26.
|
原著(症例報告除く)
|
Downregulated expression of PBRM1 in sarcomatoid hepatocellular carcinoma 2024/01
|
|
27.
|
原著(症例報告除く)
|
Direct specimen collection during routine operation improves nucleic acid quality in genetic analysis samples for head and neck tumors: A retrospective study 2023/12
|
|
28.
|
症例報告
|
Primary Gastric Rhabdomyosarcoma: A Case Report 2023/12
|
|
29.
|
原著(症例報告除く)
|
Hypoxia-inducible factor 2α protein and mRNA expression correlate with histomorphological features in clear cell renal cell carcinoma 2023/11
|
|
30.
|
症例報告
|
Adult cerebral high-grade glioneuronal tumor with perivascular or pseudopapillary growth co-existing with low-grade tumor: a case report 2023/10
|
|
31.
|
症例報告
|
Cell block-based two-dimensional and immunocytochemical analyses could reduce atypical/indeterminate case frequency in breast fine-needle aspiration cytology: a retrospective analysis 2023/10
|
|
32.
|
症例報告
|
Adenoid ameloblastoma with BRAF p.V600E mutation revealing ameloblastomatous origin: a first case report 2023/09
|
|
33.
|
原著(症例報告除く)
|
Mucous Gland Adenoma of the Lung: A Neoplastic Counterpart of Mucinous Bronchial Glands 2023/06
|
|
34.
|
症例報告
|
卵巣癌肺転移に対するラジオ波焼灼療法による気胸後に発症した膿胸 2023/05
|
|
35.
|
原著(症例報告除く)
|
気胸と誤診された巨大肺嚢胞の1例 2023/04
|
|
36.
|
原著(症例報告除く)
|
Areas of Crush Nuclear Streaming Should Be Included as Tumor Content in the Era of Molecular Diagnostics 2023/03
|
|
37.
|
症例報告
|
新規subtypeとみなされるBRAF mutationが検出されたadenoid ameloblastomaの一例 2023/03
|
|
38.
|
原著(症例報告除く)
|
Hypoxia inducible factor-1 activator munc-18-interacting protein 3 promotes tumour progression in urothelial carcinoma. 2023/02
|
|
39.
|
原著(症例報告除く)
|
MMP14 expression levels accurately predict the presence of extranodal extensions in oral squamous cell carcinoma: a retrospective cohort study 2023/02
|
|
40.
|
原著(症例報告除く)
|
Deep learning-based predictions of clear and eosinophilic phenotypes in clear cell renal cell carcinoma 2023/01
|
|
41.
|
原著(症例報告除く)
|
Significance of placental CD200 expression in patients with preeclampsia: Comparison betw
een early- and late-onset patients 2023/01
|
|
42.
|
原著(症例報告除く)
|
Small-cell neuroendocrine carcinoma of the cervix accompanied by adenocarcinoma and high-grade squamous intraepithelial lesion 2022/10
|
|
43.
|
原著(症例報告除く)
|
顆粒型側方発育型大腸腫瘍(LST-G)を病変内に認めた腸間膜静脈硬化症の1症例 2022/10
|
|
44.
|
原著(症例報告除く)
|
CD155 immunohistochemical expression in upper tract urothelial carcinoma predicts poor prognosis 2022/09
|
|
45.
|
原著(症例報告除く)
|
Development and validation of a vascularity-based architectural classification for clear cell renal cell carcinoma: correlation with conventional pathological prognostic factors, gene expression patterns, and clinical outcomes 2022/06
|
|
46.
|
原著(症例報告除く)
|
Prognostic significance of the expression levels of T-cell immunoglobulin mucin-3 and its ligand galectin-9 for relapse-free survival in triple-negative breast cancer 2022/06
|
|
47.
|
原著(症例報告除く)
|
Results of emergency salvage lung resection after chemo- and/or radiotherapy among patients with lung cancer 2022/06
|
|
48.
|
その他
|
Correction to: Development and validation of a vascularity-based architectural classification for clear cell renal cell carcinoma: correlation with conventional pathological prognostic factors, gene expression patterns, and clinical outcomes 2022/05
|
|
49.
|
原著(症例報告除く)
|
Association between fatty acid synthase and adipophilin expression in triple-negative breast cancer 2022/04
|
|
50.
|
原著(症例報告除く)
|
Clinical and molecular correlates of response to immune checkpoint blockade in urothelial carcinoma with liver metastasis 2022/04
|
|
51.
|
原著(症例報告除く)
|
Immunohistochemical analyses of the expression profiles of INSM1, ATRX, DAXX and DLL3 in solid papillary carcinomas of the breast 2022/04
|
|
52.
|
原著(症例報告除く)
|
Novel pathological predictive factors for extranodal extension in oral squamous cell carcinoma: a retrospective cohort study based on tumor budding, desmoplastic reaction, tumor-infiltrating lymphocytes, and depth of invasion 2022/04
|
|
53.
|
原著(症例報告除く)
|
Prognostic significance of adipophilin expression in biopsy specimens of patients with triple-negative breast cancer 2022/04
|
|
54.
|
症例報告
|
Useful diagnostic histogenetic features of ectopic odontogenic ghost cell tumours. 2022/04
|
|
55.
|
原著(症例報告除く)
|
Massive digital gene expression analysis reveals different predictive profiles for immune checkpoint inhibitor therapy between adenocarcinoma and squamous cell carcinoma of advanced lung cancer 2022/02
|
|
56.
|
原著(症例報告除く)
|
PBRM1 Immunohistochemical Expression Profile Correlates with Histomorphological Features and Endothelial Expression of Tumor Vasculature for Clear Cell Renal Cell Carcinoma 2022/02
|
|
57.
|
症例報告
|
Fine-needle aspiration cytology of Warthin-like mucoepidermoid carcinoma: A case report with cytological review 2022/01
|
|
58.
|
症例報告
|
Fluorescence in situ hybridization 法を用いて奇形腫との鑑別を行った後腹膜原発気管支原生嚢胞の１例 2022/01
|
|
59.
|
原著(症例報告除く)
|
Histologic-Based Tumor-Associated Immune Cells Status in Clear Cell Renal Cell Carcinoma Correlates with Gene Signatures Related to Cancer Immunity and Clinical Outcomes 2022/01
|
|
60.
|
その他
|
パンの穴 2021/12
|
|
61.
|
症例報告
|
Association of intraductal carcinoma of the prostate detected by initial histological specimen and neuroendocrine prostate cancer: A report of three cases 2021/09
|
|
62.
|
原著(症例報告除く)
|
Comprehensive assessment of PD-L1 expression, tumor mutational burden and oncogenic driver alterations in non-small cell lung cancer patients treated with immune checkpoint inhibitors 2021/09
|
|
63.
|
原著(症例報告除く)
|
Eosinophilic features in clear cell renal cell carcinoma correlate with outcomes of immune checkpoint and angiogenesis blockade 2021/09
|
|
64.
|
原著(症例報告除く)
|
Immunohistochemical comparison of three programmed death-ligand 1 (PD-L1) assays in triple-negative breast cancer 2021/09
|
|
65.
|
原著(症例報告除く)
|
PD-L1 Expression and Clinicopathological Factors in Renal Cell Carcinoma: A Comparison of Antibody Clone 73-10 With Clone 28-8 2021/09
|
|
66.
|
症例報告
|
Review of the cytological features of olfactory neuroblastoma: A retrospective single-center study 2021/08
|
|
67.
|
原著(症例報告除く)
|
Utility of an immunocytochemical analysis for pan-Trk in the cytodiagnosis of secretory carcinoma of the salivary gland 2021/08
|
|
68.
|
原著(症例報告除く)
|
Clinicopathological characteristics of pancreatic ductal adenocarcinoma with invasive micropapillary carcinoma component with emphasis on the usefulness of PKCζ immunostaining for detection of reverse polarity 2021/07
|
|
69.
|
症例報告
|
Hypercalcemia Owing to Overproduction of 1,25-Dihydroxyvitamin D 3 in Fetal Lung Adenocarcinoma: Case Report 2021/07
|
|
70.
|
原著(症例報告除く)
|
Immunohistochemical analysis of CD155 expression in triple-negative breast cancer patients 2021/06
|
|
71.
|
原著(症例報告除く)
|
Final survival results for the LURET phase II study of vandetanib in previously treated patients with RET-rearranged advanced non-small cell lung cancer 2021/05
|
|
72.
|
症例報告
|
Emergent salvage surgery for massive hemoptysis after proton beam therapy for lung cancer: a case report 2021/04
|
|
73.
|
原著(症例報告除く)
|
Induction of the epithelial-mesenchymal transition in the endometrium by chronic endometritis in infertile patients 2021/04
|
|
74.
|
原著(症例報告除く)
|
The SSPN Score, a Novel Scoring System Incorporating PBRM1 Expression, Predicts Postoperative Recurrence for Patients with Non-metastatic Clear Cell Renal Cell Carcinoma 2021/04
|
|
75.
|
原著(症例報告除く)
|
Comprehensive pathological assessment of histological subtypes, molecular subtypes based on immunohistochemistry, and tumor-associated immune cell status in muscle-invasive bladder cancer 2021/03
|
|
76.
|
症例報告
|
Isolated middle mediastinal mass associated with immunoglobulin G4-related disease 2021/03
|
|
77.
|
原著(症例報告除く)
|
p62 is a useful predictive marker for tumour regression after chemoradiation therapy in patients with advanced rectal cancer: An immunohistochemical study. 2021/03
|
|
78.
|
原著(症例報告除く)
|
Prognostic significance of PD-L1-positive cancer-associated fibroblasts in patients with triple-negative breast cancer. 2021/03
|
|
79.
|
原著(症例報告除く)
|
DNA hypermethylation of the ZNF132 gene participates in the clinicopathological aggressiveness of 'pan-negative'-type lung adenocarcinomas 2021/02
|
|
80.
|
原著(症例報告除く)
|
Presence of myxoid stromal change and fibrotic focus in pathological examination are prognostic factors of triple-negative breast cancer: Results from a retrospective single-center study. 2021/02
|
|
81.
|
症例報告
|
Signet-ring cell/histiocytoid carcinoma in the axilla: A case report with genetic analysis using next-generation sequencing 2021/01
|
|
82.
|
原著(症例報告除く)
|
Follicular pancreatitisの臨床病理学的検討 2020/12
|
|
83.
|
総説
|
Multiplex gene-panel testing for lung cancer patients 2020/12
|
|
84.
|
症例報告
|
Pulmonary Benign Metastasizing Leiomyoma Found as Multiple Bilateral Lung Nodules 11 Years after Hysterectomy;Report of a Case 2020/12
|
|
85.
|
症例報告
|
Spontaneous infarction of pleomorphic adenoma of the parotid gland: A case report 2020/12
|
|
86.
|
症例報告
|
腹式子宮全摘除後11年目に両側多発肺結節として発見された肺良性転移性平滑筋腫の1例 2020/12
|
|
87.
|
原著(症例報告除く)
|
Adipophilin expression is an independent marker for poor prognosis of patients with triple-negative breast cancer: An immunohistochemical study. 2020/11
|
|
88.
|
症例報告
|
Anomalous systemic arterial supply to the basal segment of the lung with giant aberrant artery: a case report 2020/11
|
|
89.
|
原著(症例報告除く)
|
The SSPN Score, a Novel Scoring System Incorporating PBRM1 Expression, Predicts Postoperative Recurrence for Patients with Non-metastatic Clear Cell Renal Cell Carcinoma 2020/09
|
|
90.
|
原著(症例報告除く)
|
Immunohistochemical analysis of SOX2 expression in small-cell neuroendocrine carcinoma of the endometrium 2020/08
|
|
91.
|
症例報告
|
Intramural bronchogenic cysts of the esophagus and gastroesophageal junction: A case report 2020/08
|
|
92.
|
原著(症例報告除く)
|
Prognostic impact of mucin spread, tumor cell spread, and invasive size in invasive mucinous adenocarcinoma of the lung. 2020/08
|
|
93.
|
症例報告
|
Prominent oncocytic metaplasia in pleomorphic adenoma: A potential diagnostic pitfall 2020/08
|
|
94.
|
症例報告
|
A case of IgG4-related anterior mediastinal sclerosing disease coexisting with autoimmune pancreatitis 2020/07
|
|
95.
|
原著(症例報告除く)
|
Direct comparison of magnetic resonance imaging and pathological shrinkage patterns of triple-negative breast cancer after neoadjuvant chemotherapy 2020/07
|
|
96.
|
原著(症例報告除く)
|
Preferentially expressed antigen in melanoma as a novel diagnostic marker differentiating thymic squamous cell carcinoma from thymoma 2020/07
|
|
97.
|
原著(症例報告除く)
|
Whole-exome and RNA sequencing of pulmonary carcinoid reveals chromosomal rearrangements associated with recurrence 2020/07
|
|
98.
|
その他
|
Fine-needle aspiration cytology of primary mediastinal synovial sarcoma: A case report with an immunocytochemical approach 2020/05
|
|
99.
|
その他
|
【免疫組織化学 実践的な診断・治療方針決定のために】(第1部)免疫組織化学のための病理部門運営 自動免疫染色装置 2020/04
|
|
100.
|
原著(症例報告除く)
|
Clinical impact of segmental renal vein invasion on recurrence in patients with clinical T1 renal cell carcinoma undergoing partial nephrectomy. 2020/03
|
|
101.
|
原著(症例報告除く)
|
Cytological features of carcinoma ex pleomorphic adenoma of the salivary glands: A diagnostic challenge. 2020/02
|
|
102.
|
原著(症例報告除く)
|
Low-dose CT lung cancer screening in never-smokers and smokers: results of an eight-year observational study 2020/02
|
|
103.
|
原著(症例報告除く)
|
Neuroendocrine carcinoma diagnosis from bile duct cytological specimens: A retrospective single-center study. 2020/02
|
|
104.
|
原著(症例報告除く)
|
Wagner-Meissner neurilemmoma of the lip occurring in a patient with neurofibromatosis type 1: A case report. 2020/01
|
|
105.
|
その他
|
Ciliated muconodular papillary tumor of the peripheral lungの歴史 2019/12
|
|
106.
|
原著(症例報告除く)
|
Small-cell neuroendocrine carcinoma in directly sampled endometrial cytology: A monocentric retrospective study of six cases. 2019/12
|
|
107.
|
その他
|
Immuno-oncology biomarker study in non-small cell lung cancer harboring oncogenic driver alterations: LC-SCRUM-IBIS 2019/10
|
|
108.
|
原著(症例報告除く)
|
Prognostic significance of the presence of epithelial cell clusters in the ascites of patients with pseudomyxoma peritonei. 2019/10
|
|
109.
|
症例報告
|
石灰化を伴った多房性胸腺嚢胞の1例 2019/10
|
|
110.
|
症例報告
|
A variant of acute promyelocytic leukemia with t(4;17)(q12;q21) showed two different clinical symptoms. 2019/09
|
|
111.
|
原著(症例報告除く)
|
Utility of endoscopic ultrasound-guided fine-needle aspiration cytology in rapid on-site evaluation for the diagnosis of gastric submucosal tumors: Retrospective analysis of a single-center experience. 2019/09
|
|
112.
|
原著(症例報告除く)
|
Cytological features of basal cell adenocarcinoma of the salivary glands. 2019/07
|
|
113.
|
原著(症例報告除く)
|
Simultaneous gastric adenosquamous carcinoma and gastric carcinoma with lymphoid stroma: A case report. 2019/07
|
|
114.
|
原著(症例報告除く)
|
Small-cell neuroendocrine carcinoma in directly sampled endometrial cytology: A monocentric retrospective study of six cases 2019/07
|
|
115.
|
原著(症例報告除く)
|
Tuberculosis infection and lung adenocarcinoma: Mendelian randomization and pathway analysis of genome-wide association study data from never-smoking Asian women. 2019/07
|
|
116.
|
原著(症例報告除く)
|
Collagenous crystalloids in pleomorphic adenoma of the parotid gland. 2019/06
|
|
117.
|
原著(症例報告除く)
|
Cytological features of basal cell adenoma of salivary glands: Analysis of 19 cases emphasizing stromal spindle cells. 2019/06
|
|
118.
|
原著(症例報告除く)
|
Cytological features of uterine carcinosarcoma: A retrospective study of 20 cases with an emphasis on the usefulness of endometrial cytology. 2019/06
|
|
119.
|
原著(症例報告除く)
|
Sonication of Extracted Implants Improves Microbial Detection in Patients With Orthopedic Implant-Associated Infections. 2019/06
|
|
120.
|
原著(症例報告除く)
|
Cytomorphological features of atypical polypoid adenomyoma of the endometrium. 2019/05
|
|
121.
|
原著(症例報告除く)
|
Immunohistochemical analyses to determine pathogenesis of tenosynovitis with psammomatous calcification in the wrist: A case report. 2019/05
|
|
122.
|
原著(症例報告除く)
|
Pulmonary carcinosarcoma characterized by small round cells with neuroendocrine, myogenic, and chondrogenic differentiation: An extremely rare case. 2019/05
|
|
123.
|
原著(症例報告除く)
|
Recurrent YAP1-MAML2 and YAP1-NUTM1 fusions in poroma and porocarcinoma 2019/05
|
|
124.
|
原著(症例報告除く)
|
Recurrent YAP1-MAML2 and YAP1-NUTM1 fusions in poroma and porocarcinoma. 2019/05
|
|
125.
|
原著(症例報告除く)
|
Adipophilin expression is an indicator of poor prognosis in patients with pancreatic ductal adenocarcinoma: An immunohistochemical analysis. 2019/04
|
|
126.
|
原著(症例報告除く)
|
Clinicopathological and immunological features of follicular pancreatitis-a distinct disease entity characterized by Th17 activation. 2019/04
|
|
127.
|
総説
|
肺癌診断に必要とされる適切な病理検体の取扱い 2019/04
|
|
128.
|
症例報告
|
Imprint cytology of strumal carcinoid of the ovary: A case report with immunocytochemical analysis 2019/03
|
|
129.
|
原著(症例報告除く)
|
Quantitative immunohistochemical assay with novel digital immunostaining for comparisons of PD-L1 antibodies 2019/03
|
|
130.
|
原著(症例報告除く)
|
Eosinophilic upper airway inflammation in a murine model using an adoptive transfer system induces hyposmia and epithelial layer injury with convex lesions 2019/02
|
|
131.
|
原著(症例報告除く)
|
Metastatic salivary duct carcinoma in cardiac and pleural effusions: A case report with immunocytochemical analysis for androgen receptor and HER2. 2019/01
|
|
132.
|
原著(症例報告除く)
|
Radiopathologic correlation of collision lung cancer with ground-glass opacity. 2019/01
|
|
133.
|
原著(症例報告除く)
|
Comparative study of programmed cell death ligand-1 immunohistochemistry assays using 22C3 and 28-8 antibodies for non-small cell lung cancer: Analysis of 420 surgical specimens from Japanese patients. 2018/11
|
|
134.
|
その他
|
術後肺転移を生じた胸腺原発adenocarcinoma、NOSの1例(会議録) 2018/10
|
|
135.
|
原著(症例報告除く)
|
Adenocarcinoma in situ admixed with small cell neuroendocrine carcinoma of the cervix: A case report with cytological features. 2018/09
|
|
136.
|
原著(症例報告除く)
|
Clinical and pathological characteristics of spontaneous pneumothorax in women: a 25-year single-institutional experience. 2018/09
|
|
137.
|
その他
|
【がん治療におけるコンパニオン診断】 病理医が知っておきたいコンパニオン診断 呼吸器がん(EGFR、ALK、ROS1、PD-L1など) 2018/09
|
|
138.
|
その他
|
6年ぶりに改訂された「肺癌取扱い規約(第8版)」 2018/08
|
|
139.
|
症例報告
|
Cytological features of hepatoid adenocarcinoma of the gallbladder: A case report with immunocytochemical analyzes. 2018/08
|
|
140.
|
原著(症例報告除く)
|
Cytological characteristics of meningeal solitary fibrous tumor metastatic to the lung: A case report with immunocytochemical analysis. 2018/07
|
|
141.
|
原著(症例報告除く)
|
Cytological features of mixed adenoneuroendocrine carcinoma of the ampulla of Vater: A case report with immunocytochemical analyses. 2018/06
|
|
142.
|
原著(症例報告除く)
|
Primary adenocarcinoma of the trachea revealing a mucinous bronchial gland cell origin. 2018/05
|
|
143.
|
原著(症例報告除く)
|
The first case of SMARCB1 (INI1) - deficient squamous cell carcinoma of the pleura: a case report. 2018/04
|
|
144.
|
症例報告
|
Tubular adenomas with clear cell change in the colorectum: A case with four lesions and a review of the literature. 2018/04
|
|
145.
|
症例報告
|
ランゲルハンス細胞肉腫の1例 2018/03
|
|
146.
|
原著(症例報告除く)
|
Combined small cell carcinoma with giant cell carcinoma component of the lung: A case successfully diagnosed by computed tomography-guided fine-needle aspiration cytology. 2018/02
|
|
147.
|
症例報告
|
Thymic enteric type adenocarcinoma: A case report with cytological features. 2018/01
|
|
148.
|
症例報告
|
膀胱洗浄液にみられた前立腺導管腺癌の1例 2018/01
|
|
149.
|
総説
|
低悪性度胎児型肺腺癌の一例 2018
|
|
150.
|
症例報告
|
Combined small cell lung carcinoma and giant cell carcinoma: a case report. 2017/12
|
|
151.
|
原著(症例報告除く)
|
The genomic and epigenomic landscape in thymic carcinoma. 2017/10
|
|
152.
|
その他
|
肺癌の病理組織分類 2017/10
|
|
153.
|
原著(症例報告除く)
|
Actinin-4 protein overexpression as a predictive biomarker in adjuvant
chemotherapy for resected lung adenocarcinoma 2017/09
|
|
154.
|
原著(症例報告除く)
|
PD-L1 expression in pancreatic ductal adenocarcinoma is a poor prognostic factor in patients with high CD8+ tumor-infiltrating lymphocytes: highly sensitive detection using phosphor-integrated dot staining 2017/08
|
|
155.
|
症例報告
|
Lymphoepithelioma-like hepatocellular carcinoma: a case report with emphasis on the cytological features 2017/07
|
|
156.
|
原著(症例報告除く)
|
PD-L1 expression in neuroendocrine tumors of the lung 2017/06
|
|
157.
|
症例報告
|
Thyrolipomatosis: A case report with review of the literature 2017/06
|
|
158.
|
症例報告
|
Cytological features of atypical polypoid adenomyoma of the endometrium: A case report with literature review 2017/04
|
|
159.
|
原著(症例報告除く)
|
Genomic amplification of CD274 (PD-L1) in small cell lung cancer 2017/03
|
|
160.
|
原著(症例報告除く)
|
Vandetanib in patients with previously treated RET-rearranged advanced non-small-cell lung cancer (LURET): an open-label, multicentre phase 2 trial 2017/01
|
|
161.
|
原著(症例報告除く)
|
Cavity Wall Thickness in Solitary Cavitary Lung Adenocarcinomas Is a Prognostic Indicator 2016/12
|
|
162.
|
原著(症例報告除く)
|
Clinicopathological, Immunohistochemical, and Genetic Features of Primary Lung Adenocarcinoma Occurring in the Setting of Usual Interstitial Pneumonia 2016/12
|
|
163.
|
症例報告
|
Mucinous carcinoma occurring in the ceruminous gland 2016/12
|
|
164.
|
原著(症例報告除く)
|
Expression of programmed death 1 (PD-1) and its ligand (PD-L1) in thymic epithelial tumors: Impact on treatment efficacy and alteration in expression after chemotherapy 2016/09
|
|
165.
|
原著(症例報告除く)
|
Association of variations in HLA class II and other loci with susceptibility to EGFR-mutated lung adenocarcinoma 2016/08
|
|
166.
|
原著(症例報告除く)
|
Comparison between whole mount tissue preparations and virtual tissue microarray samples for measuring Ki-67 and apoptosis indices in human bladder cancer: A cross-sectional study 2016/08
|
|
167.
|
原著(症例報告除く)
|
The novel one-step nucleic acid amplification (OSNA) assay for the diagnosis of lymph node metastasis in patients with non-small cell lung cancer (NSCLC): Results of a multicenter prospective study 2016/07
|
|
168.
|
原著(症例報告除く)
|
当院における外来由来MRSA株のPOT法による解析について 2016/07
|
|
169.
|
症例報告
|
フォスファチジルセリン依存性抗プロトロンビン抗体を認めたループスアンチコアグラント・低プロトロンビン血症症候群の1例 2016/06
|
|
170.
|
総説
|
肺がんの新しいWHO分類 2016/06
|
|
171.
|
原著(症例報告除く)
|
Efficacy of adjuvant chemotherapy for non-small cell lung cancer assessed by metastatic potential associated with ACTN4 2016/05
|
|
172.
|
その他
|
Molecular marker analysis of bad blood sampling for blood coagulation tests: experimental evaluation 2016/05
|
|
173.
|
原著(症例報告除く)
|
Medical treatment involving investigational drugs and genetic profile of thymic carcinoma 2016/03
|
|
174.
|
原著(症例報告除く)
|
Solitary fibrous tumor of the pleura: morphogenesis and progression. A report of 36 cases 2016/03
|
|
175.
|
その他
|
【肺癌I】 腺癌亜型の診断法 papillary vs acinar 2016/03
|
|
176.
|
原著(症例報告除く)
|
Alleviating effect of active hexose correlated compound (AHCC) on chemotherapy-related adverse events in patients with unresectable pancreatic ductal adenocarcinoma 2016/02
|
|
177.
|
原著(症例報告除く)
|
Frequent BRAF or EGFR mutations in ciliated muconodular papillary tumors of the lung 2016/02
|
|
178.
|
原著(症例報告除く)
|
Mucinous micropapillary pattern in lung adenocarcinomas: a unique histology with genetic correlates 2016/02
|
|
179.
|
原著(症例報告除く)
|
Multiplex Diagnosis of Oncogenic Fusion and MET Exon Skipping by Molecular Counting Using Formalin-Fixed Paraffin Embedded Lung Adenocarcinoma Tissues 2016/02
|
|
180.
|
総説
|
進化し続けるISO 15189 認定取得の光と影 困難の先に得たもの 2016/02
|
|
181.
|
原著(症例報告除く)
|
Phase I study assessing the feasibility of the triple combination chemotherapy of SOXIRI (S-1/oxaliplatin/irinotecan) in patients with unresectable pancreatic ductal adenocarcinoma 2016/01
|
|
182.
|
原著(症例報告除く)
|
Effusion cytomorphology of small round cell tumors 2016
|
|
183.
|
症例報告
|
Correction: Ultra-High-Resolution Computed Tomography of the Lung: Image Quality of a Prototype Scanner 2015/12
|
|
184.
|
症例報告
|
Expression profiling of receptor tyrosine kinases in high-grade neuroendocrine carcinoma of the lung: a comparative analysis with adenocarcinoma and squamous cell carcinoma 2015/12
|
|
185.
|
その他
|
Human herpes virus 8-unrelated primary effusion lymphoma-like lymphoma in the pericardium: A case with latency type III Epstein-Barr virus infection showing good prognosis without chemotherapy 2015/12
|
|
186.
|
症例報告
|
Retrospective analysis of the efficacy of chemotherapy and molecular targeted therapy for advanced pulmonary pleomorphic carcinoma 2015/12
|
|
187.
|
その他
|
肺癌の新しいWHO分類 2015/12
|
|
188.
|
症例報告
|
Hippo pathway gene mutations in malignant mesothelioma: revealed by RNA and targeted exon sequencing 2015/10
|
|
189.
|
症例報告
|
Impact of KRAS mutation on response and outcome of patients with stage III non-squamous non-small cell lung cancer 2015/10
|
|
190.
|
症例報告
|
Myocardial Sleeve Tissues in Surgical Lung Specimens 2015/10
|
|
191.
|
症例報告
|
Concurrent thymoma, thymic carcinoma, and T lymphoblastic leukemia/lymphoma in an anterior mediastinal mass 2015/09
|
|
192.
|
症例報告
|
Prognostic implication of PTPRH hypomethylation in non-small cell lung cancer 2015/09
|
|
193.
|
症例報告
|
Reliability of Small Biopsy Samples Compared With Resected Specimens for the Determination of Programmed Death-Ligand 1 Expression in Non--Small-Cell Lung Cancer 2015/09
|
|
194.
|
症例報告
|
Solitary Pure Ground-Glass Nodules 5 mm or Smaller: Frequency of Growth 2015/09
|
|
195.
|
症例報告
|
Ultra-High-Resolution Computed Tomography of the Lung: Image Quality of a Prototype Scanner 2015/09
|
|
196.
|
症例報告
|
Back with a vengeance: microvascular tumor embolism 2015/08
|
|
197.
|
症例報告
|
Tumour-to-tumour metastasis from papillary thyroid carcinoma with BRAF mutation to lung adenocarcinoma with EGFR mutation: the utility of mutation-specific antibodies 2015/08
|
|
198.
|
症例報告
|
Biomarker expression and druggable gene alterations for development of an appropriate therapeutic protocol for pulmonary adenosquamous carcinoma 2015/06
|
|
199.
|
症例報告
|
Ciliated muconodular papillary tumors of the lung: a clinicopathologic analysis of 10 cases 2015/06
|
|
200.
|
症例報告
|
Development of lung adenocarcinomas with exclusive dependence on oncogene fusions 2015/06
|
|
201.
|
症例報告
|
Evaluation of androgen receptor and GATA binding protein 3 as immunohistochemical markers in the diagnosis of metastatic breast carcinoma to the lung 2015/06
|
|
202.
|
症例報告
|
Expression and clinical significance of genes frequently mutated in small cell lung cancers defined by whole exome/RNA sequencing 2015/06
|
|
203.
|
その他
|
生検サンプリングの注意点 病理の立場から 2015/06
|
|
204.
|
症例報告
|
Immunohistochemical status of PD-L1 in thymoma and thymic carcinoma 2015/05
|
|
205.
|
症例報告
|
Novel use for an EGFR mutation-specific antibody in discriminating lung adenocarcinoma from reactive pneumocyte hyperplasia 2015/05
|
|
206.
|
原著(症例報告除く)
|
Beyond ALK-RET, ROS1 and other oncogene fusions in lung cancer 2015/04
|
|
207.
|
症例報告
|
The clinical relevance of the miR-197/CKS1B/STAT3-mediated PD-L1 network in chemoresistant non-small-cell lung cancer 2015/04
|
|
208.
|
症例報告
|
Desmoplastic small round cell tumor with sphere-like clusters mimicking adenocarcinoma 2015/03
|
|
209.
|
症例報告
|
Surgically resected solitary cavitary lung adenocarcinoma: association between clinical, pathologic, and radiologic findings and prognosis 2015/03
|
|
210.
|
症例報告
|
BRAF V600 mutations and pathological features in Japanese melanoma patients 2015/02
|
|
211.
|
症例報告
|
Epidermal growth factor receptor mutation is associated with longer local control after definitive chemoradiotherapy in patients with stage III nonsquamous non-small-cell lung cancer 2015/01
|
|
212.
|
症例報告
|
HER2 gene mutations in non-small cell lung carcinomas: concurrence with Her2 gene amplification and Her2 protein expression and phosphorylation 2015/01
|
|
213.
|
症例報告
|
NUT midline carcinoma of the mediastinum showing two types of poorly differentiated tumor cells: a case report and a literature review 2015/01
|
|
214.
|
原著(症例報告除く)
|
A mouse model of KIF5B-RET fusion-dependent lung tumorigenesis 2014/11
|
|
215.
|
原著(症例報告除く)
|
Oncogenic Ras/ERK signaling activates CDCP1 to promote tumor invasion and metastasis 2014/10
|
|
216.
|
原著(症例報告除く)
|
Utility of PAX8 mouse monoclonal antibody in the diagnosis of thyroid, thymic, pleural, and lung tumors: a comparison with polyclonal PAX8 antibody 2014/10
|
|
217.
|
原著(症例報告除く)
|
A three-microRNA signature predicts responses to platinum-based doublet chemotherapy in patients with lung adenocarcinoma 2014/09
|
|
218.
|
原著(症例報告除く)
|
Adjuvant chemotherapy in patients with completely resected small cell lung cancer: A retrospective analysis of 26 consecutive cases 2014/09
|
|
219.
|
原著(症例報告除く)
|
Epigenetic clustering of lung adenocarcinomas based on DNA methylation profiles in adjacent lung tissue: Its correlation with smoking history and chronic obstructive pulmonary disease 2014/07
|
|
220.
|
原著(症例報告除く)
|
Primary lung adenocarcinoma with morule-like components: A unique histologic hallmark of aggressive behavior and EGFR mutation 2014/07
|
|
221.
|
原著(症例報告除く)
|
Druggable oncogene fusions in invasive mucinous lung adenocarcinoma 2014/06
|
|
222.
|
原著(症例報告除く)
|
Image-guided bronchoscopy for histopathologic diagnosis of pure ground glass opacity: a case report 2014/06
|
|
223.
|
原著(症例報告除く)
|
Clinicopathological features in young patients treated for small cell lung cancer: Significance of immunohistological and molecular analyses 2014/05
|
|
224.
|
原著(症例報告除く)
|
Immunohistochemical detection of ROS1 is useful for identifying ROS1 rearrangements in lung cancers 2014/05
|
|
225.
|
原著(症例報告除く)
|
Molecular mechanisms underlying oncogenic RET fusion in lung adenocarcinoma 2014/05
|
|
226.
|
原著(症例報告除く)
|
ECT2 amplification and overexpression as a new prognostic biomarker for early-stage lung adenocarcinoma 2014/04
|
|
227.
|
原著(症例報告除く)
|
Pulmonary sclerosing hemangioma with lymph node metastasis: A case report and literature review. 2014/04
|
|
228.
|
原著(症例報告除く)
|
STAT6 Immunohistochemistry is helpful in the diagnosis of solitary fibrous tumors 2014/04
|
|
229.
|
原著(症例報告除く)
|
Does the mode of surgical resection affect the prognosis/recurrence in patients with thymoma? 2014/03
|
|
230.
|
原著(症例報告除く)
|
Intratumoral distribution of EGFR-amplified and EGFR-mutated cells in pulmonary adenocarcinoma 2014/03
|
|
231.
|
原著(症例報告除く)
|
Recycling and long-term storage of fluorescence in situ hybridization slides 2014/03
|
|
232.
|
原著(症例報告除く)
|
RET-rearranged non-small-cell lung carcinoma: a clinicopathological and molecular analysis 2014/03
|
|
233.
|
原著(症例報告除く)
|
Clinicopathologic features and computed tomographic findings of 52 surgically resected adenosquamous carcinomas of the lung 2014/01
|
|
234.
|
原著(症例報告除く)
|
Clinicopathological features of nonsmall cell lung carcinomas with BRAF mutations 2014/01
|
|
235.
|
原著(症例報告除く)
|
Combined high-grade neuroendocrine carcinoma of the lung: Clinicopathological and immunohistochemical study of 34 surgically resected cases 2014/01
|
|
236.
|
原著(症例報告除く)
|
NEK9-dependent proliferation of cancer cells lacking functional p53 2014
|
|
237.
|
原著(症例報告除く)
|
p40 is the best marker for diagnosing pulmonary squamous cell carcinoma: Comparison with p63, cytokeratin 5/6, desmocollin-3, and sox2 2014
|
|
238.
|
症例報告
|
成人T細胞性白血病の化学療法中に播種性糞線虫症となった1剖検例 2002
|
|
239.
|
症例報告
|
Cytologic features of a primary myxoid malignant fibrous histiocytoma arising in the uterus: a case report. 2001
|
|
240.
|
原著(症例報告除く)
|
Growth inhibitory effects of diallyl disulfide on human breast cancer cell lines. 2001
|
|
241.
|
原著(症例報告除く)
|
Mechanisms of adrenal damage induced by 7,12-dimethylbenz (alpha) anthrancene in female Sprague--Dawley rats. 2001
|
|
242.
|
原著(症例報告除く)
|
Effects of genistein and synergistic action in combination with eicosapentaenoic acid on the growth of breast cancer cell lines. 2000
|
|
243.
|
原著(症例報告除く)
|
Influence of perinatal genistein exposure on the development of MNU-induced mammary carcinoma in female Sprague-Dawley rats. 2000
|
|
244.
|
原著(症例報告除く)
|
ゲニステインとエイコサペンタエン酸によるヒト乳癌細胞増殖抑制における相乗効果． 2000
|
|
245.
|
症例報告
|
左腋窩原発のアポクリン腺癌の1剖検例−その肺転移巣、胸水、喀痰、尿における細胞像−． 2000
|
|
246.
|
その他
|
生期植物性エストロゲン（Genistein）暴露によるラットMNU誘発乳癌に対する影響． 2000
|
|
247.
|
総説
|
剖検例よりみた深在性真菌症の解析と課題． 2000
|
|
5件表示
|
|
全件表示(247件)
|
